RATIONALE: Chronic abacterial prostatitis (CAP) results from cytokine induced inflammation which impacts prostatic secretions. The efficacy of treatment for CAP using a combination of sodium diclofenac, tamsulosin and the extract of Serenoarepens was assessed including impact on cytokine production. METHODS: 32 patients with CAP aged 18-45 years were assessed using microscopy and culture evaluation of ejaculate. Patients received diclofenac sodium (100 mg/day, orally, 2 weeks), tamsulosin (0.4 mg/day, orally, 1 month), and Serenoarepens extract (320 mg/day, orally, 6 months). Levels of TNF-a and IL-10 in ejaculate were assessed pre-and post-treatment. RESULTS: Treatment significantly decreased dysuria and pain (NIH-CPSI scale, uroflowometry). Improvement in patients was observed in 47% after 2 weeks, in 63% after 1 month, and in 72% after 6 months. In patients with good results at 6 months, recurrence of symptoms of SAP occurred in 10%, but re-introduction of diclofenac and tamsulosin induced remission in all cases of relapse. Adverse effects included epigastrium pain in 10% due ot diclofenac use of more than 7 days, and retrograde ejaculation in 78% due to tamsulosin. Drug withdrawal was not required. A significant decrease in concentration (p<0.05) of TNF-a and increase IL-10 occurred, but in 34% cytokine levels were normal. CONCLUSIONS: The assessed treatment regimen for CAP increased the immune-regulatory cytokine IL-10 and decreased the inflammatory cytokine TNF-a while improving symptoms and urine flow. 1 Siolta Therapeutics, San Francisco, CA, 2 UCSF, San Francisco, CA. RATIONALE: The gut microbiome develops in early life and is essential to the establishment and maintenance of peripheral immune tolerance. Infants who develop allergy and asthma in childhood harbor a distinct gut microbiota depleted of a range of bacteria and functional gene pathways; perturbations that are evident from birth and throughout the first year of life. METHODS: Using longitudinal gut microbiota data generated from stool samples collected over the first year of life and clinical data from a San Francisco-based birth cohort of healthy and high risk for asthma infants, we designed a mixed-species bacterial consortium that encodes a broad range of functional gene pathways depleted in high-risk infants. To evaluate the efficacy of our consortium, we utilized a cockroach allergen (CRA) airway sensitization model in C57BL/6J mice supplemented with or without this bacterial consortium. RESULTS: CRA sensitization induces an allergic response characterized by activation and expansion of antigen-specific T H 2 cells in lung and draining lymph nodes and elevated serum concentrations of immunoglobulin E (IgE) and histamine. Mice orally supplemented with the bacterial consortium exhibited significantly lower T H 2 cell numbers and associated inflammatory cytokine expression, reduced airway eosinophilia and circulating IgE and histamine. Reduced allergic sensitization was coincident with higher numbers of regulatory T cells in lamina propria and lung tissues. CONCLUSIONS: Manipulation of the gut microbiome with a rationally designed bacterial consortium reduces allergic sensitization in a murine model. Supplementation of high-risk infants may influence gut microbiome development and promote immune tolerance in humans.
The gut microbiome develops in early life and is essential to the establishment and maintenance of peripheral immune tolerance. Infants who develop allergy and asthma in childhood harbor a distinct gut microbiota depleted of a range of bacteria and functional gene pathways; perturbations that are evident from birth and throughout the first year of life. METHODS: Using longitudinal gut microbiota data generated from stool samples collected over the first year of life and clinical data from a San Francisco-based birth cohort of healthy and high risk for asthma infants, we designed a mixed-species bacterial consortium that encodes a broad range of functional gene pathways depleted in high-risk infants. To evaluate the efficacy of our consortium, we utilized a cockroach allergen (CRA) airway sensitization model in C57BL/6J mice supplemented with or without this bacterial consortium. RESULTS: CRA sensitization induces an allergic response characterized by activation and expansion of antigen-specific T H 2 cells in lung and draining lymph nodes and elevated serum concentrations of immunoglobulin E (IgE) and histamine. Mice orally supplemented with the bacterial consortium exhibited significantly lower T H 2 cell numbers and associated inflammatory cytokine expression, reduced airway eosinophilia and circulating IgE and histamine. Reduced allergic sensitization was coincident with higher numbers of regulatory T cells in lamina propria and lung tissues. CONCLUSIONS: Manipulation of the gut microbiome with a rationally designed bacterial consortium reduces allergic sensitization in a murine model. Supplementation of high-risk infants may influence gut microbiome development and promote immune tolerance in humans.
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Epitope Mapping of 2S albumins and Comparison of Ara h 2, Ara h 6 and Ara h 7 from Peanut Barry K. Hurlburt, PhD, Hsiaopo Cheng, MS, and Soheila J. Maleki, PhD FAAAAI; USDA-Agricultural Research Service, New Orleans, LA. RATIONALE: Peanut allergy is increasing worldwide. Of all the peanut allergens identified, Ara h 2 has been shown to be most correlated with and diagnostic of peanut allergy. In this work, we probed peptide microarrays with peanut allergic sera to identify and compare the linear epitopes of the peanut conglutinins, Ara h 2, Ara h 6 and Ara h 7 and other potentially cross-reactive tree nut 2S albumins. METHODS: 15-mer peptides that were offset by 5 amino acids were printed on glass slides. Patient sera were incubated with the slides. IgE and IgG4 binding was detected with a combination of fluorescently-labelled antibodies. The linear epitopes were mapped to molecular models of the 3-dimensional structures of the allergens. RESULTS: The majority of the epitopes mapped to the surface of the proteins. In addition, while Ara h 6 and Ara h 7 share 77% and 60% homology with Ara h 2, respectively, not all epitopes identified in these conglutins were shared among the three allergens. Common epitopes of cross-reactive 2S albumins in tree nuts were identified. CONCLUSIONS: These results not only identify important epitopes for 2S albumins as well as Ara h 6 and 7, they demonstrate that while the peanut conglutins share some epitopes, they also have their own unique IgE and IgG4 epitopes and are not necessarily diagnostically or immunologically equivalent to Ara h 2. Recently we identified CC027/GeniUnc mice to be reactive upon oral challenge with peanut extract, following gastric sensitization with peanut plus cholera toxin (CT). Here, we aimed to determine if CT was critical for breaking oral tolerance. METHODS: Female CC027/GeniUnc, C3H/HeJ and BALB/cJ mice, aged 4-6 weeks, were sensitized by the gastric route for four weeks with either (1) PBS, (2) peanut extract once/week, (3) peanut extract three times/ week, or (4) peanut extract plus CT once/week. Mice were challenged with peanut extract via oral gavage one week after sensitization. Fecal pellets and serum were collected at baseline and one day before oral challenges. Mice were bled 60 minutes following the challenge to measure mediators and Ara h 2 in the serum. RESULTS: Following oral challenge with peanut, CC027/GeniUnc mice sensitized with peanut alone, once or three times/week, experienced anaphylaxis (>38C body temperature decrease), comparable to mice sensitized with peanut plus CT. Contrarily, all groups of C3H/HeJ and BALB/cJ did not experience anaphylaxis. CC027/GeniUnc mice sensitized with peanut once/week had higher levels of peanut-specific IgE, IgG1 and IgG2a post-sensitization compared to C3H/HeJ and BALB/cJ (p<0.05). CC027/GeniUnc serum levels of Ara h 2 post-challenge were correlated with reaction severity (p50.0004). All groups of CC027/ GeniUnc mice produced minimal total fecal IgA post-sensitization, while C3H/HeJ and BALB/cJ mice produced higher levels of fecal IgA. CONCLUSIONS: These results demonstrate that CC027/GeniUnc can be intragastrically sensitized to peanut alone, indicating an innate failure of oral tolerance. Low fecal IgA may be an important factor that makes them susceptible to sensitization.
